PL377345A1 - Sposób wytwarzania sterylnych zawiesin wodnych do inhalacji, zawierających rozdrobnione do mikrocząstek krystaliczne składniki aktywne - Google Patents

Sposób wytwarzania sterylnych zawiesin wodnych do inhalacji, zawierających rozdrobnione do mikrocząstek krystaliczne składniki aktywne

Info

Publication number
PL377345A1
PL377345A1 PL377345A PL37734503A PL377345A1 PL 377345 A1 PL377345 A1 PL 377345A1 PL 377345 A PL377345 A PL 377345A PL 37734503 A PL37734503 A PL 37734503A PL 377345 A1 PL377345 A1 PL 377345A1
Authority
PL
Poland
Prior art keywords
preparation
active ingredients
sterile aqueous
aqueous suspensions
inhalation
Prior art date
Application number
PL377345A
Other languages
English (en)
Other versions
PL213704B1 (pl
Inventor
Andrea Capocchi
Fausto Pivetti
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of PL377345A1 publication Critical patent/PL377345A1/pl
Publication of PL213704B1 publication Critical patent/PL213704B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/68—Treatment of water, waste water, or sewage by addition of specified substances, e.g. trace elements, for ameliorating potable water
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
    • C02F2103/02—Non-contaminated water, e.g. for industrial water supply
    • C02F2103/026—Treating water for medical or cosmetic purposes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
PL377345A 2002-12-18 2003-12-17 Sposób wytwarzania sterylnych preparatów w postaci wodnej zawiesiny PL213704B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002674A ITMI20022674A1 (it) 2002-12-18 2002-12-18 Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione.

Publications (2)

Publication Number Publication Date
PL377345A1 true PL377345A1 (pl) 2006-01-23
PL213704B1 PL213704B1 (pl) 2013-04-30

Family

ID=32587870

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377345A PL213704B1 (pl) 2002-12-18 2003-12-17 Sposób wytwarzania sterylnych preparatów w postaci wodnej zawiesiny

Country Status (23)

Country Link
US (1) US8128909B2 (pl)
EP (1) EP1572153B1 (pl)
CN (1) CN100398095C (pl)
AT (1) ATE544445T1 (pl)
AU (1) AU2003294879A1 (pl)
BR (1) BRPI0316908B8 (pl)
CA (1) CA2510263C (pl)
DK (1) DK1572153T3 (pl)
EA (1) EA008122B1 (pl)
ES (1) ES2379349T3 (pl)
HK (1) HK1088217A1 (pl)
HR (1) HRP20050546B1 (pl)
IT (1) ITMI20022674A1 (pl)
MA (1) MA27702A1 (pl)
ME (2) ME01084B (pl)
MX (1) MXPA05006441A (pl)
PL (1) PL213704B1 (pl)
PT (1) PT1572153E (pl)
RS (1) RS52151B (pl)
SI (1) SI1572153T1 (pl)
UA (1) UA87655C2 (pl)
WO (1) WO2004054545A1 (pl)
ZA (1) ZA200504897B (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9704186D0 (sv) 1997-11-14 1997-11-14 Astra Ab New composition of matter
ITMI20020808A1 (it) * 2002-04-17 2003-10-17 Chiesi Farma Spa Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7811606B2 (en) * 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
ITMI20032054A1 (it) * 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
EP1949891A1 (en) * 2004-10-12 2008-07-30 Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
US9808423B2 (en) 2004-10-12 2017-11-07 Generics [Uk] Limited Preparation of suspension aerosol formulations
EP1683514B1 (en) 2005-01-20 2012-05-23 Eratech S.r.l. Process for the preparation of concentrated suspensions of drugs and kit thereof
EP1782797A1 (en) * 2005-11-02 2007-05-09 Pharmatex Italia Srl Process for the preparation of sterile powdered pharmaceutical compounds.
CA2683712A1 (en) * 2007-04-20 2009-01-15 Sun Pharmaceutical Industries Limited Pharmaceutical compositions
PT2170279T (pt) * 2007-07-31 2018-04-06 Otsuka Pharma Co Ltd Métodos para produção de suspensão de aripiprazole e formulação liofilizada
AU2008334547B2 (en) * 2007-12-13 2011-06-30 Novartis Ag Organic compounds
GB0806873D0 (en) * 2008-04-16 2008-05-21 Breath Ltd Steroid nebuliser formulation
CN101618019B (zh) * 2008-07-01 2011-08-03 上海通用药业股份有限公司 一种醋酸曲安奈德微粒及其制备方法和药物组合物
AU2012206621B2 (en) * 2011-01-12 2017-04-27 Intervet International B.V. Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions
EP2704724B1 (en) 2011-05-03 2016-10-26 Chiesi Farmaceutici S.p.A. Improved suspension formulation of beclometasone dipropionate for administration by inhalation
JP4954345B1 (ja) * 2011-07-06 2012-06-13 アピ株式会社 医薬品原薬の無菌化精製装置
MX361886B (es) * 2012-05-08 2018-12-18 Nicox Ophthalmics Inc Preparaciones de agentes terapéuticos hidrófobos, métodos de elaboración y uso de los mismos.
DE102012221219B4 (de) * 2012-11-20 2014-05-28 Jesalis Pharma Gmbh Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel
JP6502501B2 (ja) 2014-09-09 2019-04-17 ベクトゥラ・リミテッド グリコピロレートを含む製剤、方法、及び装置
ES2764495T3 (es) * 2015-10-09 2020-06-03 Bgh Procedimiento para cristalizar clatratos hidratos y procedimiento de purificación de un líquido acuoso usando los clatratos hidratos así cristalizados

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2107715B (en) * 1981-10-19 1985-11-13 Glaxo Group Ltd Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
CN1145478C (zh) * 1998-04-18 2004-04-14 葛兰素集团有限公司 药用气溶胶制剂
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
IT1303692B1 (it) * 1998-11-03 2001-02-23 Chiesi Farma Spa Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.
GB0015981D0 (en) 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0016040D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
US8541399B2 (en) * 2002-02-19 2013-09-24 Resolution Chemicals Limited Solvent-based sterilisation of pharmaceuticals

Also Published As

Publication number Publication date
BRPI0316908B8 (pt) 2021-05-25
RS52151B (en) 2012-08-31
BR0316908A (pt) 2005-10-18
RS72504A (en) 2006-10-27
HK1088217A1 (en) 2006-11-03
HRP20050546B1 (hr) 2014-05-23
CA2510263A1 (en) 2004-07-01
US20070140980A1 (en) 2007-06-21
EP1572153B1 (en) 2012-02-08
BRPI0316908B1 (pt) 2016-01-26
MA27702A1 (fr) 2006-01-02
ZA200504897B (en) 2006-09-27
SI1572153T1 (sl) 2012-05-31
CN1735403A (zh) 2006-02-15
EA200500833A1 (ru) 2006-02-24
PL213704B1 (pl) 2013-04-30
WO2004054545A1 (en) 2004-07-01
ITMI20022674A1 (it) 2004-06-19
ES2379349T3 (es) 2012-04-25
ME01084B (me) 2011-05-10
HRP20050546A2 (en) 2005-10-31
UA87655C2 (ru) 2009-08-10
ATE544445T1 (de) 2012-02-15
AU2003294879A1 (en) 2004-07-09
PT1572153E (pt) 2012-03-22
MXPA05006441A (es) 2005-09-08
CN100398095C (zh) 2008-07-02
MEP35208A (en) 2011-02-10
CA2510263C (en) 2012-07-03
DK1572153T3 (da) 2012-03-05
EA008122B1 (ru) 2007-04-27
US8128909B2 (en) 2012-03-06
EP1572153A1 (en) 2005-09-14

Similar Documents

Publication Publication Date Title
HK1088217A1 (en) Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
HUP0302086A2 (hu) Késleltetett hatású orális gyógyászati készítmény és eljárás az előállítására
WO2004037807A3 (en) Medicinal arylethanolamine compounds
HK1079986B (zh) 製備用於通過吸入給藥的皮質類固醇微粒的無菌混懸液的方法
WO2003082853A8 (en) New compounds
TW200736223A (en) N-(pyridin-2-yl)-sulfonamide derivatives
PL364598A1 (pl) Stabilna odmiana polimorficzna flibanseryny, techniczny sposób jej wytwarzania i jej zastosowanie do otrzymywania leków
RS98704A (en) New pharmaceutical compositions containing flibanserin polymorpha
IL150528A0 (en) Ibuprofen containing active agent preparation
TW200745155A (en) Preparation of pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl)betulinic acid
HK1075894A1 (en) Prucalopride-n-oxide
MXPA02009210A (es) Modificacion amorfa de torasemida.
WO2004043486A8 (en) An acqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism
AU2003294834A1 (en) Anthranilic acid amide derivatives and their pharmaceutical use
TW200505427A (en) A solid oral dosage form of metformin and glyburide and the method of preparation thereof
AU2003288107A1 (en) Tiotropium-containing medicament combinations used for inhaling
AU2003298203A1 (en) Medicaments containing substituted 2,5-diaminomethyl-1h-pyrroles
TW200742581A (en) Medicament containing thiazole derivative